Mutations profile in Chinese patients with hypertrophic cardiomyopathy

Clinica Chimica Acta

Volumn 351, Issue 1-2, 2005, Pages 209-216

  Song, Lei ^a   Zou, Yubao ^a   Wang, Jizheng ^a   Wang, Zhimin ^a   Zhen, Yisong ^a   Lou, Kejia ^a   Zhang, Qian ^a   Wang, Xiaojian ^a   Wang, Hu ^a   Li, Jia ^a   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Chinese; Hypertrophic cardiomyopathy; Mutation; Phenotype

Indexed keywords

ARTICLE; CAUCASIAN; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; ECG ABNORMALITY; FAMILIAL DISEASE; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RACE DIFFERENCE; SYNCOPE;

ADOLESCENT; ADULT; AGE OF ONSET; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHINA; DNA MUTATIONAL ANALYSIS; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; EXONS; FEMALE; GENE FREQUENCY; HUMANS; MALE; MUTATION; PENETRANCE; PHENOTYPE;

EID: 9444255079     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.09.016     Document Type: Article

References (30)

1. K.R. Chien Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies J. Clin. Invest. 111 2003 175 178
2. A.J. Marian On genetic and phenotypic variability of hypertrophic cardiomyopathy: nature versus nurture J. Am. Coll. Cardiol. 38 2001 331 334
3. J.G. Seidman, and C. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms Cell 104 2001 557 567
4. M. Lechin, M.A. Quinones, A. Omran, R. Hill, Q.T. Yu, and H. Rakowski Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy Circulation 92 1995 1808 1812
5. A.P. Osterop, M.J. Kofflard, L.A. Sandkuijl, F.J. ten Cate, R. Krams, and M.A. Schalekampj AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy Hypertension 32 1998 825 830
6. P. Jaaskelainen, J. Kuusisto, R. Miettinen, P. Karkkainen, S. Karkkainen, and S. Heikkinen Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland J. Mol. Med. 80 2002 412 422
7. S. Morner, P. Richard, E. Kazzam, U. Hellman, B. Hainque, and K. Schwartz Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden J. Mol. Cell. Cardiol. 35 2003 841 849
8. X. Huang, L. Song, A.Q. Ma, J. Gao, W. Zheng, and X. Zhou A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gln cardiac beta-myosin heavy-chain mutation in a Chinese family Clin. Chim. Acta 310 2001 131 139
9. M. Kupari, A. Hautanen, L. Lankinen, P. Koskinen, J. Virolainen, and H. Nikkila Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function Circulation 97 1998 569 575
10. Y. Zou, L. Song, Z. Wang, A. Ma, T. Liu, and H. Gu Prevalence of idiopathic hypertrophic cardiomyopathy in Chinese-a cross sectional population based echocardiographic analysis of 8080 adults Am. J. Med. 116 2004 14 18
11. W.J. McKenna, P. Spirito, M. Desnos, O. Dubourg, and M. Komajda Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families Heart 77 1997 130 132
12. E. Dausse, M. Komajda, L. Fetler, O. Dubourg, C. Dufour, and L. Carrier Familial hypertrophic cardiomyopathy: microsatellite haplotyping and identification of a hot-spot for mutations in the β-myosin heavy chain gene J. Clin. Invest. 92 1993 2807 2813
13. P. Richard, P. Charron, L. Carrier, C. Ledeuil, T. Cheav, and C. Pichereau Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy Circulation 107 2003 2227 2232
14. B.J. Maron, W.K. Shen, M.S. Link, A.E. Epstein, A.K. Almquist, and J.P. Daubert Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N. Engl. J. Med. 342 2000 365 373
15. P. Spirito, C.E. Seidman, W.J. McKenna, and B.J. Maron The management of hypertrophic cardiomyopathy N. Engl. J. Med. 336 1997 775 785
16. O.M. Hess Risk stratification in hypertrophic cardiomyopathy: fact or fiction? J. Am. Coll. Cardiol. 42 2003 880 881
17. W.J. McKenna, and E.R. Behr Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death Heart 87 2002 169 176
18. J.C. Moolman, V.A. Corfield, B. Posen, K. Ngumbela, C. Seidman, and P.A. Brink Sudden death due to troponin T mutations J. Am. Coll. Cardiol. 29 1997 549 555
19. H. Niimura, L.L. Bachinski, S. Sangwatanaroj, H. Watkins, A.E. Chudley, and W. McKenna Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy N. Engl. J. Med. 338 1998 1248 1257
20. N.D. Epstein, G.M. Cohn, F. Cyran, and L. Fananapazir Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu- - - -Val mutation and a 403Arg- - - -Gln mutation Circulation 86 1992 345 352
21. A.A. Geisterfer-Lowrance, S. Kass, G. Tanigawa, H.P. Vosberg, W. McKenna, and C.E. Seidman A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation Cell 62 1990 999 1006
22. H. Watkins, A. Rosenzweig, D.S. Hwang, T. Levi, W. McKenna, and C.E. Seidman Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy N. Engl. J. Med. 326 1992 1108 1114
23. R. Anan, G. Greve, L. Thierfelder, H. Watkins, W.J. McKenna, and S. Solomon Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy J. Clin. Invest. 93 1994 280 285
24. M. Enjuto, A. Francino, F. Navarro-Lopez, D. Viles, J.C. Pare, and A.M. Ballesta Malignant hypertrophic cardiomyopathy caused by the Arg723Gly mutation in beta-myosin heavy chain gene J. Mol. Cell. Cardiol. 32 2000 2307 2313
25. H. Watkins, W.J. McKenna, L. Thierfelder, H.J. Suk, R. Anan, and A. O'Donoghue Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy N. Engl. J. Med. 332 1995 1058 1064
26. J.C. Moolman-Smook, W.J. De Lange, E.C. Bruwer, P.A. Brink, and V.A. Corfield The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events Am. J. Hum. Genet. 65 1999 1308 1320
27. J. Erdmann, S. Daehmlow, S. Wischke, M. Senyuva, U. Werner, and J. Raible Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy Clin. Genet. 64 2003 339 349
28. S.L. Van Driest, M.J. Ackerman, S.R. Ommen, R. Shakur, M.L. Will, and R.A. Nishimura Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy Circulation 106 2002 3085 3090
29. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, and C.E. Seidman Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J. Am. Coll. Cardiol. 42 2003 1687 1713
30. A. Woo, H. Rakowski, J.C. Liew, M.S. Zhao, C.C. Liew, and T.G. Parker Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis Heart 89 2003 1179 1185